Market Report, "KineMed, Inc. - Product Pipeline Analysis, 2014 Update", Published
KineMed, Inc. (KineMed) is a biotechnology company. The company discovers and develops biomarkers. Its services include pre-clinical, clinical activity and patient stratification data. The company's patented isotopic tracer technology helps clients in tracking chemical pathways within living systems. KineMed concentrates in the therapeutic areas of muscle metabolism, proteome metabolism, inflammation, immunity, neurobiology, plasma lipids and lipoproteins, pancreatic islet cell proliferation and lipid synthesis. Its product pipeline includes KM-011 - apo-A1 and noscapine and noscapine analogues. KineMed is headquartered in Emeryville,...
View full press release